Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in patients with MASH and liver fibrosis.

Welcome to the third-quarter 2024 Novo Nordisk A/S earnings conference call. [Operator instructions] Please be advised that ...

Reports 9M 2024 net sales DKK 204.72B vs. DKK 166.4B last year. Lars Fruergaard Jorgensen, president and CEO, said: “We are pleased with ...

Novo Nordisk AS (NVO) reports strong financial performance with a 24% sales increase, driven by demand for diabetes and ...

The Corner Booth The Quebec Liberals want semaglutide — also known as Ozempic — to be covered by medicare for weight loss.

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

Archaeologists working at Tel Shimron in northern Israel have uncovered an enormous ancient structure filled with Canaanite cultic artifacts. This remarkable collection includes objects likely used in ...

Israel State Auditor Holds Tax Authority Accountable for $800M Crypto Tax Gap: Report ...